GatePass Capital LLC purchased a new position in Cigna Group (NYSE:CI – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 2,175 shares of the health services provider’s stock, valued at approximately $580,000.
A number of other institutional investors have also recently made changes to their positions in the company. apricus wealth LLC lifted its holdings in shares of Cigna Group by 715.9% during the 4th quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock valued at $2,616,000 after buying an additional 8,340 shares during the period. CIBC Bancorp USA Inc. bought a new stake in shares of Cigna Group in the third quarter worth $10,617,000. Wilsey Asset Management Inc. grew its holdings in shares of Cigna Group by 5.1% in the fourth quarter. Wilsey Asset Management Inc. now owns 110,801 shares of the health services provider’s stock worth $30,496,000 after acquiring an additional 5,327 shares during the period. Nisa Investment Advisors LLC increased its position in Cigna Group by 3.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 105,534 shares of the health services provider’s stock valued at $29,046,000 after acquiring an additional 3,814 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in Cigna Group by 4.8% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 95,023 shares of the health services provider’s stock valued at $27,068,000 after acquiring an additional 4,394 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Insider Transactions at Cigna Group
In other news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.
Cigna Group Stock Down 0.7%
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the prior year, the company posted $6.74 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current year.
Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s payout ratio is presently 26.45%.
Analyst Ratings Changes
CI has been the subject of a number of recent research reports. Raymond James Financial set a $340.00 price target on Cigna Group in a research note on Friday, May 1st. Jefferies Financial Group lowered their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. UBS Group upped their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Morgan Stanley increased their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Finally, Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $338.80.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories
- Five stocks we like better than Cigna Group
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
